BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 1, 2026
Home » Topics » In the clinic, BioWorld

In the clinic, BioWorld
In the clinic, BioWorld RSS Feed RSS

In the clinic for Sept. 23, 2022

Sep. 23, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adamis, Alaunos, Almirall, Biomind, Carsgen, DBV, Nanobiotix, Neurona, Nodthera, Revolution, RVAC, Sonnet, Spexis, Telix, Vir.
Read More

In the clinic for Sept. 22, 2022

Sep. 22, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arcutis, Corium, Genelux, Mapi.
Read More

In the clinic for Sept. 21, 2022

Sep. 21, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aobiome, Alzheon, Arecor, Atriva, Charsire, Clene, Clover, EIP, Evaxion, GNT, Glyscend, Immunic, Merck, Mindmedicine, Nicox, PDS, Pfizer, Pionyr, Poxel, Relmada, Remegen, Rhythm, Sage, Satsuma, Tiziana, Vistagen, Wave, Zealand.
Read More

In the clinic for Sept. 20, 2022

Sep. 20, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biogen, Cellresearch, Corium, Neurosense, Novartis, Polypid, Revance, Trevi, Virios.
Read More

In the clinic for Sept. 19, 2022

Sep. 19, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzecure, Astrazeneca, Intellia, Oryzon, Regeneron, Revive, Sanofi.
Read More

In the clinic for Sept. 16, 2022

Sep. 16, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, Alnylam, Ascletis, Biojiva, Brainstorm Cell, Bristol Myers Squibb, Celsion, Curevo, Eloxx, Excision, Inhibikase, Navidea, Omeros, Pfizer, Regeneron.
Read More

In the clinic for Sept. 15, 2022

Sep. 15, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Alligator, Almirall, Altimmune, Ascendis, Cidara, Effector, Fresh Tracks, Horizon, Locus, MC2, Nascent, NGM, Pfizer, Sagimet, Sensorion.
Read More

In the clinic for Sept. 14, 2022

Sep. 14, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adamis, Akero, Amolyt, Bioatla, Eli Lilly, Lyra, Nanoscope, On Target, Oramed, Rayzebio, Recursion Selection Sonalasense, Vaxxinity.
Read More

In the clinic for Sept. 13, 2022

Sep. 13, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Agenus, Biomed, BMS, Cabaletta, Concert, Dynavax, Entera, Horizon, Keros, Lyra, Novartis, Pharnext, Regulus, Revolo.
Read More

In the clinic for Sept. 12, 2022

Sep. 12, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ABVC, Allakos, Arcutis, Astrazeneca, Innocare, Merck, Regeneron, Sanofi, Sparrow.


Read More
Previous 1 2 … 89 90 91 92 93 94 95 96 97 … 166 167 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 29, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 30, 2026
  • Digital brain with dollar sign

    Investors bet on transformative BCI tech for neuro disorders

    BioWorld
    An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
  • Dollar sign inside vial, syringe

    BIO 2026: Alternatives to funding orphan drugs

    BioWorld
    At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...
  • Illustration demonstrating gut-brain axis

    CINP 2026: Gut microbiota could predict antidepressant response

    BioWorld
    The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing